This article addresses common questions that clinicians face when treating pregnant women
with opioid dependence. Guidance, based on both research evidence and the collective …

This article provides an overview and discussion of the collective maternal, fetal and
neonatal outcome research on women maintained on methadone or buprenorphine during …

Opioid use in pregnancy is not uncommon, and the use of illicit opioids during pregnancy is
associated with an increased risk of adverse outcomes. The current standard of care for …

Opioid dependence has been studied with regard to its effects on the woman, the fetus, and
the child for the past three decades, and it continues to be a serious problem that must be …

Objectives: To compare maternal characteristics, prenatal care, and newborn outcomes in a
cohort of opioid-dependent pregnant women treated with methadone versus buprenorphine …

Objectives: The prevalence of opioid use disorder (OUD) during pregnancy is increasing.
Practical recommendations will help providers treat pregnant women with OUD and reduce …

Aims Through a novel synthesis of the literature and our own clinical experience, we have
derived a set of evidence‐based recommendations for consideration as guidance in the …

Given that buprenorphine+ naloxone is prescribed for opioid-dependent pregnant women, it
is important to examine the extent to which it differs from buprenorphine alone, methadone …

Opioid dependent pregnant and postpartum women and their infants are a complex and
vulnerable population requiring individualized, comprehensive, and multidisciplinary …

Pregnant women with opioid use disorder can be treated with methadone, buprenorphine,
or naltrexone to reduce opioid use and improve retention to treatment. In this review, we …